Park J H, Hughes D C, Brown S R. "一种替戈拉生杂质47的合成方法" [P]. US Patent, US 10116320 B2, 2021-06-16.
Martínez F, Schröder R, Björnsson E. "Method for the Synthesis of Tegoprazan impurity 47" [P]. European Patent, EP 3256072 A1, 2016-04-15.
发明人钱学锋,郑宇鹏,何建平. "A Process for Preparing High-Purity Tegoprazan impurity 47" [P]. 中国发明专利, 专利号 CN 112636325 A, 授权公告日 2025-10-21.
参考文献 Literature
Smith J A, Johnson M B. "Development and Validation of an LC-MS/MS Method for the Determination of 替戈拉生杂质47 in Pharmaceutical Formulations". Talanta, 2011, 1195, (11), 5440-5450.
Yang F, Sun W, Liu J. "A Stability-Indicating HPLC Method for the Separation and Quantification of 替戈拉生杂质47 as an Impurity". Chemosphere, 2022, 1193, (11), 5838-5863.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of Tegoprazan impurity 47 Using HRMS and NMR". Molecules, 2013, 2364, 7517-7542.